Navigation Links
InVitria Cell Culture Product Line to Headline PEACe
Date:9/16/2009

InVitria to showcase its high performance cell culture media supplements at 9th Annual Conference on Protein Expression in Animal Cells (PEACe) in Jackson Hole, WY, Sept. 19-23.

Fort Collins, CO (PRWEB) September 16, 2009 -- InVitria will showcase its line of high performance, well defined and regulatory friendly cell culture media supplements at the 9th Annual PEACe conference to be held in Jackson Hole, WY, Sept. 19-23.

A major part of the PEACe conference is the industrial workshop session, where InVitria's Director of Cell Culture Optimization, Dr. Steve Pettit, will present two of the company's newest cell culture products for CHO Cell Culture and Hybridoma Cell Culture: Zap-CHO and Optiferrin.

About Zap-CHO
"Zap-CHO is a CHO cell culture media supplement that delivers superior growth, faster cell line development and expansion and optimal productivity," said Dr. Pettit. "Additionally, it replaces fetal bovine serum (FBS) in CHO cell culture with a well defined and completely animal component free supplement. This enables biomanufacturing customers to eliminate the risk of virus and other infectious contaminants emanating from animal-derived media components like fetal bovine serum," he said.

About Optiferrin
Optiferrin is an animal-free recombinant human transferrin that efficiently delivers iron to cells including stem cells, primary cells, CHO and hybridoma cells. "Optiferrin is a preferred alternative to iron chelators or animal-derived transferrin in cell culture," said Dr. Pettit. "Optiferrin transfers iron to cells so that they receive exactly the amount of iron it needs for growth," he continued.

InVitria's sponsorship of PEACe kick-offs the fall industry events tour. "InVitria is extremely excited to be a part of PEACe," said Randy Semadeni, InVitria's Vice President of Business Development. "We see PEACe as an ideal event to interact with dynamic leaders from the mammalian cell culture industry while also sharing the powerful benefits of InVitria's line of high performance cell culture media supplements."

About InVitria
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media components and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.

For more information about InVitria's product line, contact us at 1-800-916-8311.

###

Read the full story at http://www.prweb.com/releases/Zap-CHO/CHO-cell-culture-media/prweb2887874.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. InVitria Sponsors ESACT 2009 in Dublin, Ireland
2. InVitria to Present at BIO 2009 International Convention in Atlanta
3. InVitria Reveals Technology to Optimize Hybridoma Production Performance
4. InVitria Headlines Sponsorship of WilBio's Waterside Conference
5. InVitria Announces Launch of Recombinant Albumin for Diagnostics
6. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
7. InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
8. InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego
9. InVitria to Showcase its Innovative Cell Culture Components at American Society of Cell Biology Annual Meeting
10. InVitria to Present at WilBio's International Cell Engineering Meeting
11. New Survey Identifies Specialized Training and Respect for Culture as Key Factors in Healthcare Security Personnel Selection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... Wells Pharmacy ... attending prescribers at the upcoming World Congress, in Hollywood Florida April 6-8, 2017. ... recognized as the visionary leader in the training of physicians, scientists, and members ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... insight into the challenges employers face in trying to balance both short-term and ... benefits programs? Adding to the growing complexity, companies are finding that the ...
(Date:3/29/2017)... (PRWEB) , ... March 29, ... ... Manufacturer Alliance (GRMA) is growing as it continues developing an ANSI-approved, consensus-based ... industry. The organization, which plans to publish the first ANSI-approved GMP standard ...
(Date:3/29/2017)... ... March 29, 2017 , ... Curio Wellness , a ... the finalization of the company’s executive management team with prominent executives from both inside ... Curio Wellness’ Chief Operating Officer, Ted Dumbauld , who has more than twenty ...
(Date:3/29/2017)... ... March 29, 2017 , ... The assembly of synthetic DNA ... many repetitive steps and often scientists require many different versions of DNA. Therefore, ... results in a lower error rate and cost saving for reagents and consumables. ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017 Avelas Biosciences, Inc., a ... diagnosis through treatment, today announced that Carmine N. Stengone , ... company at the Needham & Company 16 th Annual Healthcare ... a.m. PDT) at the Westin Grand Central Hotel in ... ...
(Date:3/29/2017)... 2017 Research and Markets has announced the addition ... Centers & Forecast" report to their offering. ... Proton Therapy Market in Italy ... in 2016. There are currently three proton therapy centers in ... patients. In Italy , the first patients were treated ...
(Date:3/29/2017)... , Mar. 29, 2017 Research and Markets has ... Policy, Patients Treated at Proton Therapy Centers & Forecast" report to ... The South ... its current market size in 2016. The Untapped Proton Therapy Market for ... Billion USD in 2016. Proton Therapy plays an important ...
Breaking Medicine Technology: